| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | bitter taste receptor activity | 5.83e-05 | 27 | 56 | 3 | GO:0033038 | |
| GeneOntologyMolecularFunction | taste receptor activity | 1.07e-04 | 33 | 56 | 3 | GO:0008527 | |
| Domain | FAT | 1.18e-04 | 6 | 53 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 1.18e-04 | 6 | 53 | 2 | IPR003151 | |
| Domain | HAT | 3.50e-04 | 10 | 53 | 2 | IPR003107 | |
| Domain | HAT | 3.50e-04 | 10 | 53 | 2 | SM00386 | |
| Domain | TAS2R | 2.46e-03 | 26 | 53 | 2 | PF05296 | |
| Domain | T2R | 2.46e-03 | 26 | 53 | 2 | IPR007960 | |
| Domain | Serpin_CS | 3.71e-03 | 32 | 53 | 2 | IPR023795 | |
| Domain | Serpin_dom | 4.68e-03 | 36 | 53 | 2 | IPR023796 | |
| Domain | SERPIN | 4.94e-03 | 37 | 53 | 2 | SM00093 | |
| Domain | SERPIN | 4.94e-03 | 37 | 53 | 2 | PS00284 | |
| Domain | Serpin | 5.20e-03 | 38 | 53 | 2 | PF00079 | |
| Domain | Serpin_fam | 5.47e-03 | 39 | 53 | 2 | IPR000215 | |
| Domain | HEAT | 8.20e-03 | 48 | 53 | 2 | PF02985 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 17702579 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 15537898 | ||
| Pubmed | 5.43e-05 | 407 | 57 | 6 | 12693553 | ||
| Pubmed | 8.22e-05 | 51 | 57 | 3 | 24510904 | ||
| Pubmed | 1.44e-04 | 11 | 57 | 2 | 38518774 | ||
| Pubmed | The human TAS2R16 receptor mediates bitter taste in response to beta-glucopyranosides. | 1.72e-04 | 12 | 57 | 2 | 12379855 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 1.95e-04 | 736 | 57 | 7 | 29676528 | |
| Pubmed | 1.96e-04 | 515 | 57 | 6 | 31617661 | ||
| Pubmed | 2.03e-04 | 13 | 57 | 2 | 15938754 | ||
| Pubmed | A Genome-wide CRISPR Death Screen Identifies Genes Essential for Oxidative Phosphorylation. | 2.03e-04 | 13 | 57 | 2 | 27667664 | |
| Pubmed | Identification and characterization of human taste receptor genes belonging to the TAS2R family. | 2.03e-04 | 13 | 57 | 2 | 12584440 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 3.40e-04 | 807 | 57 | 7 | 22681889 | |
| Pubmed | 5.32e-04 | 405 | 57 | 5 | 38187761 | ||
| Pubmed | 5.43e-04 | 21 | 57 | 2 | 10761934 | ||
| Pubmed | Evolutionary relationships of the Tas2r receptor gene families in mouse and human. | 5.97e-04 | 22 | 57 | 2 | 12734386 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 6.16e-04 | 639 | 57 | 6 | 23443559 | |
| Pubmed | The molecular receptive ranges of human TAS2R bitter taste receptors. | 6.53e-04 | 23 | 57 | 2 | 20022913 | |
| Pubmed | 7.73e-04 | 25 | 57 | 2 | 20301702 | ||
| Pubmed | 7.73e-04 | 25 | 57 | 2 | 12139982 | ||
| Pubmed | Molecular mechanisms of bitter and sweet taste transduction. | 8.36e-04 | 26 | 57 | 2 | 11696554 | |
| Pubmed | 9.02e-04 | 27 | 57 | 2 | 12581520 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 9.52e-04 | 695 | 57 | 6 | 23602568 | |
| Pubmed | 1.04e-03 | 29 | 57 | 2 | 24105743 | ||
| Pubmed | Mapping of QTLs for oral alcohol self-administration in B6.C and B6.I quasi-congenic RQI strains. | 1.11e-03 | 30 | 57 | 2 | 17273929 | |
| Pubmed | Adaptive diversification of bitter taste receptor genes in Mammalian evolution. | 1.11e-03 | 30 | 57 | 2 | 12679530 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 1.13e-03 | 989 | 57 | 7 | 36424410 | |
| Pubmed | 1.15e-03 | 125 | 57 | 3 | 19019335 | ||
| Pubmed | Preterm birth in Caucasians is associated with coagulation and inflammation pathway gene variants. | 1.23e-03 | 128 | 57 | 3 | 18818748 | |
| Pubmed | Racial disparity in pathophysiologic pathways of preterm birth based on genetic variants. | 1.23e-03 | 128 | 57 | 3 | 19527514 | |
| Pubmed | 1.32e-03 | 496 | 57 | 5 | 31343991 | ||
| Pubmed | 1.43e-03 | 34 | 57 | 2 | 15496549 | ||
| Pubmed | 1.47e-03 | 136 | 57 | 3 | 25429064 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q33 | 1.18e-04 | 205 | 56 | 4 | chr2q33 | |
| Cytoband | 2q33 | 5.81e-04 | 29 | 56 | 2 | 2q33 | |
| Cytoband | 12p13.2 | 1.40e-03 | 45 | 56 | 2 | 12p13.2 | |
| GeneFamily | Taste 2 receptors | 5.79e-05 | 39 | 35 | 3 | 1162 | |
| GeneFamily | Serpin peptidase inhibitors | 2.32e-03 | 37 | 35 | 2 | 739 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.61e-06 | 157 | 56 | 5 | 84f629b7f589ca8a1abc220fa740c4a6fdc1b579 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.88e-06 | 188 | 56 | 5 | fe7143c36e4a883745862d3c3147cf751b440e46 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.88e-06 | 188 | 56 | 5 | cbf32b675a7cd0c808d5c9c22dfa7fa79fbe2437 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-06 | 200 | 56 | 5 | 3653002c805c314043e2a7b0c9980dfe952dc53e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-06 | 200 | 56 | 5 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.22e-05 | 154 | 56 | 4 | 1f8d127b657976656e4ec292f26d619943533b86 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.78e-05 | 159 | 56 | 4 | 2233fee5dcdb6c7dee5b1bd8efbc07d86b339927 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.90e-05 | 160 | 56 | 4 | c2b5fadb4bac17fafc08831f6d3f4ff96ada7e70 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.65e-05 | 166 | 56 | 4 | 76b4cd32698900797ec009f17e50ea7ae36b85f4 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.65e-05 | 166 | 56 | 4 | 30a991fc3275b571d53bd0976df4789e5d40b01d | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.06e-05 | 169 | 56 | 4 | 225aec04ba762d4c55885257de03a65b63503fbb | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.06e-05 | 169 | 56 | 4 | 278960f940b646a788360b1c84d641a8d169896b | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.20e-05 | 170 | 56 | 4 | 054360a3b05f5e41221c98b122d241b1affad26a | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.20e-05 | 170 | 56 | 4 | f0b0d2d0402de3ed7322284a599646db43475761 | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_Tfh|normal_Lung / Location, Cell class and cell subclass | 6.63e-05 | 173 | 56 | 4 | e8ead6c51c41dbd43c717ba9d1a7a0ab39c79330 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 6.63e-05 | 173 | 56 | 4 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 6.78e-05 | 174 | 56 | 4 | e324320b52c904496e26fcecfa179b3431729ec0 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.74e-05 | 180 | 56 | 4 | 162cec1734e560c068cd61717e40e18dcf92308c | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 7.74e-05 | 180 | 56 | 4 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.74e-05 | 180 | 56 | 4 | 33c86c22ba877358cd8c1e39b5c0b3dc3a45b7dd | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_3|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.25e-05 | 183 | 56 | 4 | 228092290dbb08785c4eda224e3ad03e99e10fab | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.96e-05 | 187 | 56 | 4 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 9.15e-05 | 188 | 56 | 4 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-05 | 189 | 56 | 4 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.34e-05 | 189 | 56 | 4 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 9.53e-05 | 190 | 56 | 4 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | (6)_Endothelial-C_(Capillary_Aerocyte_)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.01e-04 | 193 | 56 | 4 | f7f2dc6aff02d096a282835094d26d12b3b73e61 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.03e-04 | 194 | 56 | 4 | 777ce41c3f22c591e2d81120f189b834e53ffb4b | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-04 | 197 | 56 | 4 | 86591849476b3925857a82b6913f65e74df200c1 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.12e-04 | 198 | 56 | 4 | 9ecf944984aade1bf902e3a92ea4d46a3696822f | |
| ToppCell | medial-2-Endothelial-Capillary_Aerocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.14e-04 | 199 | 56 | 4 | c5048b31649a0b7eddcd481b0458ed96508f5561 | |
| ToppCell | medial-Endothelial-Capillary_Aerocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.14e-04 | 199 | 56 | 4 | 84e30c39c2f050aa64af167999824c1cba32ba05 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.14e-04 | 199 | 56 | 4 | a900ef002e1ae583b70be0253d8c44dae6754916 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-04 | 199 | 56 | 4 | 1621ce2968f3100e4c39e0ef8293232a5d76c614 | |
| ToppCell | medial-Endothelial-Capillary_Aerocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.14e-04 | 199 | 56 | 4 | f1039d1ab498fc58f0feba545df05833c235db74 | |
| ToppCell | distal-Endothelial-Capillary_Aerocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.14e-04 | 199 | 56 | 4 | 9021f4be004efd51bb3658e5bbff53589356b3df | |
| ToppCell | distal-Endothelial-Capillary_Aerocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-04 | 200 | 56 | 4 | b91f8eb67752a77e1e08e462e50f1b5923695e1b | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 200 | 56 | 4 | 105c67e4f5eff036013d655c8e8ac577d32dae2e | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-04 | 200 | 56 | 4 | 16a70cc07dcfb4eba4385b712f27010c6629ff67 | |
| Disease | amyloidosis (is_implicated_in) | 1.97e-05 | 4 | 54 | 2 | DOID:9120 (is_implicated_in) | |
| Disease | triacylglycerol 54:9 measurement | 2.14e-04 | 12 | 54 | 2 | EFO_0010427 | |
| Disease | Graves ophthalmopathy (is_marker_for) | 2.53e-04 | 13 | 54 | 2 | DOID:0081120 (is_marker_for) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.52e-04 | 195 | 54 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | lysophosphatidylcholine 22:6 measurement | 4.94e-04 | 18 | 54 | 2 | EFO_0010365 | |
| Disease | hypertension (biomarker_via_orthology) | 7.98e-04 | 227 | 54 | 4 | DOID:10763 (biomarker_via_orthology) | |
| Disease | lysophosphatidylcholine 18:0 measurement | 8.84e-04 | 24 | 54 | 2 | EFO_0010359 | |
| Disease | Depressive Symptoms | 1.04e-03 | 26 | 54 | 2 | C0086132 | |
| Disease | lysophosphatidylethanolamine 18:1 measurement | 1.78e-03 | 34 | 54 | 2 | EFO_0010368 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HFAIAMDKFGFRLPY | 236 | O60909 | |
| FGAFKHLYMLLVNAF | 181 | Q8N8R5 | |
| GFKAMLAAFLENHYF | 106 | Q5NE16 | |
| DPIMYFFVAEKFRHA | 321 | Q13304 | |
| LQMEFLYHNKFSDFP | 861 | Q8WZ64 | |
| YRVVFHFEFFPFMNL | 546 | Q96F81 | |
| GFLPFRLDHIRKMAY | 256 | P49759 | |
| MFYAHFVLSKRGPLA | 1 | O60216 | |
| MKPRADVAFHFNPRF | 56 | O00214 | |
| AMLAERKFFLSHPAY | 251 | Q9UQ16 | |
| KQHFAFMYRTILPGF | 291 | Q9UL01 | |
| TKPHAGFRIAFNMFD | 231 | Q86XE3 | |
| VMSRLDHPFFVKLYF | 106 | Q6A1A2 | |
| SNFPKGMLLRFFVHF | 841 | P78344 | |
| LMAARKAFDRFFIHY | 111 | Q86UA1 | |
| FFMLFLIAKHPNVEE | 316 | P11511 | |
| FFMAPPHQLEFIQKF | 506 | Q9NSG2 | |
| SVMKHRFLFPFFDSA | 211 | P17174 | |
| MAFRVHLFYKNGQPF | 76 | O15033 | |
| FRKDPDINMHPFFFA | 226 | O60427 | |
| DINMHPFFFALGKIL | 231 | O60427 | |
| TVPDGFRIKLYFMHF | 51 | P48740 | |
| FEHTYFGPFDLRAMK | 31 | Q6UWN5 | |
| GPKFIHLMYHFARFV | 121 | Q7Z4H7 | |
| FFLLFIPVFCKAMHV | 26 | P16410 | |
| HKFLPYALLAFAAIM | 121 | Q96RD6 | |
| LKLVQGFMPHFFRLF | 126 | P05121 | |
| ESKVFMRALFHYNPR | 226 | Q13368 | |
| KFSLPPEAFYMIRFH | 206 | Q9UGB7 | |
| FMFCKAIRFSYPSIH | 261 | P59538 | |
| FMFCKAIRFSYPSIH | 261 | P0DSN6 | |
| FMFCKAIRFSYPSIH | 261 | P59537 | |
| RDLQMDFYPHFPEFF | 116 | O75691 | |
| YVHTFMNVCFFPRLK | 1236 | Q9NRR4 | |
| LPRFLFFGMHGFLDE | 241 | B2RXF0 | |
| SLKNFFAMPFRQHLD | 631 | Q8NDG6 | |
| KKMGERFNFFALLPH | 396 | Q7L592 | |
| HRPSFYAERFFKFMS | 426 | O60331 | |
| RFEKRLMFSHPAFNQ | 201 | Q9NYY8 | |
| VASAVKRPFHFMANF | 836 | Q1XH10 | |
| DHKAMVPFGFPEFFR | 221 | Q9P2F8 | |
| FFPSDKIVHYRQMFL | 316 | Q96QE5 | |
| MRAQFKANHPFLFFI | 361 | Q96P15 | |
| HKPMYFFLANLSFLE | 56 | O95007 | |
| MARLFYHKPQFAILD | 581 | P28288 | |
| MDAVPDKVHFFNSFF | 596 | Q96HI0 | |
| GVHYIMFAFFPDNFK | 351 | P32241 | |
| KLNIFLTGMNPFYFH | 101 | Q8IUR5 | |
| EQLMFPFHFVDRLGK | 311 | P82933 | |
| MAFCALIHKFFPDAF | 411 | A8MU46 | |
| FFAAHLLDIAMGFKT | 4641 | Q15413 | |
| MLQDSFPARFKAIHF | 226 | P12271 | |
| DRFMNAVFFLLPKFH | 2376 | P78527 | |
| FLRAMKLGEEAFFYH | 101 | Q9P016 | |
| QKDRMDFEAFFSHPF | 256 | Q8IYT8 | |
| MFSFNMFDHPIPRVF | 1 | Q92890 | |
| MLVFYQFFHPCKKLF | 366 | P51811 | |
| LYHMAKAFALQIFPE | 451 | Q96CT2 | |
| FGDKMFHPHTLFDQF | 226 | Q5VXJ0 |